Gels· 2026Q1
Copper Peroxide-Loaded Dual-Responsive Hydrogel for Enhanced Diabetic Wound Healing Through Oxygen Release and Promotion of Angiogenesis
- 0citations
- Q1SCImago
- 2026year
Short summary
A novel glucose/pH-responsive hydrogel (CuO2/CBOD) loaded with copper peroxide nanoparticles accelerates diabetic wound closure to nearly 100% by day 14 in rats by releasing oxygen and copper ions, modulating inflammation, and promoting blood vessel formation.
AI-generated from the title and abstract; the full text is not read.
Key points
- A glucose/pH-responsive hydrogel (CuO2/CBOD) was developed for diabetic wound healing.
- The hydrogel releases oxygen and copper ions in response to acidic pH and high glucose.
- In diabetic rats, CuO2/CBOD achieved nearly 100% wound closure by day 14.
- Treatment modulated inflammatory markers (reduced M1, increased M2) and promoted angiogenesis (increased CD31, α-SMA).
AI-generated from the title and abstract; the full text is not read.
Abstract
Diabetic foot ulcers (DFUs) present a major clinical challenge because of persistent hyperglycemia, hypoxia, impaired angiogenesis, and chronic inflammation. Conventional dressings have limited capacity to modulate these pathological processes. Here, we report a glucose/pH dual-responsive hydrogel, denoted CBOD, constructed through a dynamic covalent network comprising Schiff base and boronate ester bonds between phenylboronic acid-grafted chitosan (CS-BA) and dopamine-modified oxidized sodium alginate (OSA-DA). Copper peroxide (CuO2) nanoparticles are encapsulated within this network to form CuO2/CBOD. Under acidic (pH 5.5) and high-glucose conditions, competitive binding and bond hydrolysis promote network relaxation, facilitating the stimuli-dependent release of oxygen and copper ions. In vitro assessments demonstrate good cytocompatibility and enhanced migration and tube formation of human umbilical vein endothelial cells (HUVECs). In a diabetic rat model of full-thickness excisional wounds, the hydrogel accelerates wound closure, with closure approaching 100% by day 14. Treatment is associated with reduced expression of the M1-associated markers interleukin-1β (IL-1β) and cluster of differentiation 80 (CD80), increased expression of the M2-associated markers interleukin-10 (IL-10) and cluster of differentiation 163 (CD163), and enhanced expression of the vascular markers cluster of differentiation 31 (CD31) and alpha-smooth muscle actin (α-SMA). These findings support the potential of CuO2/CBOD as a multifunctional dressing for diabetic wound management.
The authors' abstract, as published at the source. Gels, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Rehabilitation
RehabilitationMedicine